Clinical Trial Update: Effect of Tirzepatide on Markers of MASLD in Patients With Obesity [EARLY_Phase 1]

View source ↗

Summary

An early-phase trial evaluating the effect of tirzepatide on markers of metabolic dysfunction-associated steatotic liver disease in adults with obesity, current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Dysfunction-associated Steatotic Liver Disease
• Obesity

Drugs mentioned

• MOUNJARO (tirzepatide)

Snippet

Sponsor: University of New Mexico | Conditions: MASLD, Obesity | EARLY_Phase 1 | Status: RECRUITING